According to Smith & Nephew 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.4708. At the end of 2014 the company had a P/S ratio of 3.58.
Year | P/S ratio | Change |
---|---|---|
2014 | 3.58 | 22.91% |
2013 | 2.91 | 21.39% |
2012 | 2.40 | 19.06% |
2011 | 2.02 | -14.64% |
2010 | 2.36 | -1.95% |
2009 | 2.41 | 60.42% |
2008 | 1.50 | -50.84% |
2007 | 3.05 | -14.06% |
2006 | 3.55 | -39.43% |
2005 | 5.87 | 45.41% |
2004 | 4.03 | 8.53% |
2003 | 3.72 | -45.63% |
2002 | 6.84 | -9.85% |
2001 | 7.58 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 4.10 | 65.86% | ๐บ๐ธ USA |
Boston Scientific BSX | 7.08 | 186.68% | ๐บ๐ธ USA |
Edwards Lifesciences EW | 9.57 | 287.29% | ๐บ๐ธ USA |
Stryker Corporation SYK | 6.65 | 169.33% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | 0.7275 | -70.56% | ๐บ๐ธ USA |
CONMED CNMD | 1.98 | -19.85% | ๐บ๐ธ USA |